Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The new small-animal scanner for the Wellcome Centre for Integrative Neuroimaging is lifted into place at the Biomedical Services Building

The installation of this new small bore 7T MRI scanner heralds exciting new opportunities to image and discover more about the brain across species.

The ability to record comparable signals and study comparable behaviours across species allows us to address causal and mechanistic questions in animal models and translate these findings directly to humans.

We aim to discover cross-species homologies in brain anatomy, functional specialisation and computation. Outputs will include cross-species brain atlases as well as a shared repository of cross-species behavioural paradigms.

This will not only provide fundamental new scientific knowledge but will also enable mechanistic questions that are addressed in rodent and macaque models, to be seamlessly translated to human and clinical populations.

Similar stories

New European initiative to accelerate the discovery and validation of biomarkers for neurodegenerative diseases

Members of the European Platform for Neurodegenerative Diseases (EPND) will establish a collaborative platform for efficient sample and data sharing, linking existing European research infrastructures to accelerate the discovery of biomarkers, new diagnostics and treatments for the benefit of people with neurodegenerative diseases such as Alzheimer's and Parkinson's.

Experimental Medicine and Industry Partnership

The recent launch event of the Experimental Medicine Industry Partnership was an exciting collaboration between industry representatives and researchers from the University of Oxford. During the event, a series of workshops were held to discuss opportunities, challenges, and future directions for the application of experimental medicine in psychiatric drug development.

Major research network to investigate body clock and stroke

The University of Oxford is part of a new international research network to investigate the interactions between the biology of the body's internal clock and the disordered physiological processes associated with stroke.

Mapping uncharted networks in the progression of Parkinson’s

A major new $9 million project funded by the Aligning Science Across Parkinson’s (ASAP) initiative will map the original circuits vulnerable to Parkinson’s on an unprecedented scale. The project is a collaboration between a core team of Stephanie Cragg, Richard Wade-Martins, and Peter Magill at Oxford, Mark Howe at Boston University and Dinos Meletis at the Karolinska Institute, as well as collaborators Yulong Li at Peking University and Michael Lin at Stanford University.